Stay updated on IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.

Latest updates to the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.4 was added as the latest entry in the history, replacing Revision: v3.5.3. This documents an update to the record version rather than content changes to the study data.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedUpdates the page’s displayed software/version identifier from the previous revision to the current one.SummaryDifference0.1%

- Check32 days agoChange DetectedA new site revision v3.5.2 was added and the previous revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check60 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3 from the record history.SummaryDifference0.1%

- Check75 days agoChange DetectedNew revision entry v3.4.3 added to the history and the v3.4.2 entry removed.SummaryDifference0.1%

- Check97 days agoChange DetectedThe page shows an addition of Revision: v3.4.2 and a removal of Revision: v3.4.1, which are administrative site updates that do not affect study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.